Literature DB >> 6604544

Changes in histone H3 composition and synthesis pattern during lymphocyte activation.

R S Wu, S Tsai, W M Bonner.   

Abstract

Freshly isolated human lymphocytes were found to synthesize histones at a significant rate even though no DNA was being synthesized. The synthesis pattern of histone variants in resting lymphocytes is similar to that found in other quiescent cells and different from that found in S-phase cells. For this reason, the histone synthesis in resting lymphocytes cannot be attributed to contamination by S-phase cells. Stimulation by the mitogen phytohemagglutinin resulted in a dramatic switch in the histone H3 variant synthesis pattern as well as a readily apparent change in the histone H3 mass pattern. Thus, the chromatin of activated lymphocytes has a different histone H3 variant composition than resting or quiescent lymphocytes. It is suggested that the proportion of H3.3 in the mass pattern of the chromatin of a cell may be related solely to how long that cell has been quiescent. Inducing resting lymphocytes to synthesize DNA by UV irradiation did not qualitatively change the histone variant synthesis pattern. No S-phase H3 variants were induced by the repair process. Furthermore, the quantity of histone synthesized neither increased nor decreased after treatment with UV light.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6604544     DOI: 10.1021/bi00285a023

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  20 in total

1.  Essential factors determining codon usage in ubiquitin genes.

Authors:  K Mita; S Ichimura; M Nenoi
Journal:  J Mol Evol       Date:  1991-09       Impact factor: 2.395

2.  Phosphorylated fraction of H2AX as a measurement for DNA damage in cancer cells and potential applications of a novel assay.

Authors:  Jiuping Ji; Yiping Zhang; Christophe E Redon; William C Reinhold; Alice P Chen; Laura K Fogli; Susan L Holbeck; Ralph E Parchment; Melinda Hollingshead; Joseph E Tomaszewski; Quentin Dudon; Yves Pommier; James H Doroshow; William M Bonner
Journal:  PLoS One       Date:  2017-02-03       Impact factor: 3.240

3.  Nucleosomal histones of transcriptionally active/competent chromatin preferentially exchange with newly synthesized histones in quiescent chicken erythrocytes.

Authors:  M J Hendzel; J R Davie
Journal:  Biochem J       Date:  1990-10-01       Impact factor: 3.857

4.  Codon usage in histone gene families of higher eukaryotes reflects functional rather than phylogenetic relationships.

Authors:  D Wells; W Bains; L Kedes
Journal:  J Mol Evol       Date:  1986       Impact factor: 2.395

5.  Unusual structure, evolutionary conservation of non-coding sequences and numerous pseudogenes characterize the human H3.3 histone multigene family.

Authors:  D Wells; D Hoffman; L Kedes
Journal:  Nucleic Acids Res       Date:  1987-04-10       Impact factor: 16.971

6.  Changes in the levels of three different classes of histone mRNA during murine erythroleukemia cell differentiation.

Authors:  D T Brown; S E Wellman; D B Sittman
Journal:  Mol Cell Biol       Date:  1985-11       Impact factor: 4.272

7.  High histone variant H3.3 content in mouse prospermatogonia suggests a role in epigenetic reformatting.

Authors:  Michelle C W Tang; Steve Binos; Eng K Ong; Lee H Wong; Jeffrey R Mann
Journal:  Chromosoma       Date:  2014-07-10       Impact factor: 4.316

8.  Structure of a human histone cDNA: evidence that basally expressed histone genes have intervening sequences and encode polyadenylylated mRNAs.

Authors:  D Wells; L Kedes
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

9.  Remodeling of the H3 nucleosomal landscape during mouse aging.

Authors:  Yilin Chen; Juan I Bravo; Jyung Mean Son; Changhan Lee; Bérénice A Benayoun
Journal:  Transl Med Aging       Date:  2020-01-03

10.  Nucleotide sequences of new members (H3-IV and H3-V) of the chicken H3 histone-encoding gene family.

Authors:  Y Setoguchi; T Nakayama
Journal:  Nucleic Acids Res       Date:  1991-11-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.